EUVIMEDEUVIMED entdecken
Crossref

Accuracy of endobronchial ultrasound‐guided transbronchial needle aspiration for staging of non‐small cell lung cancer

Kimberley Chung, Jacqueline Bentel iD, Andrew Laycock

Diagnostic Cytopathology · 2024

DOI: 10.1002/dc.25282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostic Cytopathology, 2024. Verfasst von Kimberley Chung und 2 weiteren Autor:innen. Beteiligte Einrichtung: PathWest Anatomical Pathology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) is routinely performed to confirm a lung cancer diagnosis and/or to clinically stage disease. EBUS‐TBNA findings may be used to determine whether patients can be offered potentially curative surgery. In this study, we evaluated the reporting in our service of EBUS‐TBNA cytology for early‐stage (operable) non‐small cell lung cancer (NSCLC), focusing on diagnostic accuracy and analyzing cases with discordant cytologic and post‐surgical histopathologic conclusions.

Methods

Cytology slides and cytopathology reports of 120 NSCLC patients who had undergone EBUS‐TBNA and lobectomy in our hospital system between 2015 and 2021 were retrospectively reviewed.

Results

Of 290 lymph nodes (110 cases) able to be reviewed, interpretation of 48 lymph nodes was discordant with the original cytopathology report. This included 31 lymph nodes originally reported as adequate, which were found to be non‐diagnostic on review. The diagnostic accuracy (benign/malignant) of lymph nodes that were sampled at EBUS‐TBNA and excised at surgery was 89%. Specific examination of cases where EBUS‐TBNA cytology did not reflect post‐surgical findings illustrated important features and limitations of the procedure. These included potential misclassification of lymph node stations, the presence of multiple, variably involved nodes at lymph node stations, and the failure to detect small volume disease.

Conclusions

Continuous evaluation of EBUS‐TBNA performance identifies technical limitations and areas of improvement for cytopathology reporting. This is increasingly important in an era where lung cancer screening is expected to increase diagnosis of early‐stage disease and with the advent of novel treatments, including non‐surgical management options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHumansRetrospective StudiesEarly Detection of CancerMediastinumEndoscopic Ultrasound-Guided Fine Needle AspirationLymph NodesNeoplasm StagingBronchoscopy

Stichwörter der Autor:innen

EBUS‐TBNAclinical stagingcytopathologynon‐small cell lung cancer

Autor:innen und Institutionen

  • PathWest Anatomical Pathology, Fiona Stanley Hospital, Murdoch, Western Australia, Australia.

ORCID-Profile: Jacqueline Bentel

Zitieren

APA

Chung, K., Bentel, J., & Laycock, A. (2024). Accuracy of endobronchial ultrasound‐guided transbronchial needle aspiration for staging of non‐small cell lung cancer. Diagnostic Cytopathology. https://doi.org/10.1002/dc.25282

Vancouver

Chung K, Bentel J, Laycock A. Accuracy of endobronchial ultrasound‐guided transbronchial needle aspiration for staging of non‐small cell lung cancer. Diagnostic Cytopathology. 2024. doi:10.1002/dc.25282

BibTeX
@article{Chung2024,
  author = {Chung, Kimberley and Bentel, Jacqueline and Laycock, Andrew},
  title = {Accuracy of endobronchial ultrasound‐guided transbronchial needle aspiration for staging of non‐small cell lung cancer},
  journal = {Diagnostic Cytopathology},
  year = {2024},
  doi = {10.1002/dc.25282}
}
Kostenlos starten →